Multiple biological cofactors have been shown to increase a woman's susceptibility to HIV-1 infection, including sexually transmitted diseases, vaginal flora, hormonal contraceptive use and pregnancy. Many of these factors cause inflammation or immune activation, suggesting a possible mechanism for their affect on HIV-1 susceptibility. The proposed aims of this project will test the hypothesis that innate immune conditions, including immune activation and inflammation, impact HIV-1 susceptibility in women. The foundation for this hypothesis comes from many observations, including the above-mentioned results suggesting that several of the biological cofactors for HIV-1 acquisition alter innate immunity, the fact that immune activation is known to make CD4+T lymphocytes more permissive to infection, and the fact that immune activation early in HIV-1 infection appears to fuel virus replication and disease progression. Although there are several lines of support for this hypothesis, the association between inflammation or immune activation has never been directly examined in relation to risk of HIV-1 acquisition in women. We propose to test this hypothesis by examining cytokine profiles, which provide a surrogate marker of innate immune conditions, just prior to the time of HIV-1 infection, in relation to risk of HIV-1 infection in several populations. The cohorts for these studies will include a 14 year seroincident female cohort in Mombasa, Kenya and a cohort of pregnant women in Nairobi, Kenya. We will take advantage of banked samples and clinical data from the Mombasa cohort as well as samples and data collected as part of Projects 1 and 2 to address the Aims of Project 3. This integration with long-term cohort studies by our group and with the new studies in other Projects will provide considerable opportunities for synergy among projects in the program grant. It will also permit a comprehensive study of innate immune factors at the time of HIV-1 acquisition across multiple high-risk cohorts that will include women with various biological cofactors of importance in determining risk of HIV-1 acquisition in women.

Public Health Relevance

These studies will provide critical data on the characteristics of the innate immune response that impact risk of HIV-infection in women, including women in multiple high-risk groups. In addition, the study is designed to identify a cytokine profile that is associated with increase risk of HIV acquisition in women. This profile may provide a useful surrogate marker for monitoring the impact of new prevention methods, particularly microbicides.

National Institute of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-TP-A)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Fred Hutchinson Cancer Research Center
United States
Zip Code
Heffron, Renee; McClelland, R Scott; Balkus, Jennifer E et al. (2017) Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study. Lancet HIV 4:e449-e456
Pintye, Jillian; Drake, Alison L; Unger, Jennifer A et al. (2017) Male partner circumcision associated with lower Trichomonas vaginalis incidence among pregnant and postpartum Kenyan women: a prospective cohort study. Sex Transm Infect 93:137-143
Kinuthia, John; Richardson, Barbra A; Drake, Alison L et al. (2017) Sexual Behavior and Vaginal Practices During Pregnancy and Postpartum: Implications for HIV Prevention Strategies. J Acquir Immune Defic Syndr 74:142-149
Lokken, Erica M; Balkus, Jennifer E; Kiarie, James et al. (2017) Association of Recent Bacterial Vaginosis With Acquisition of Mycoplasma genitalium. Am J Epidemiol 186:194-201
Pintye, Jillian; Drake, Alison L; Kinuthia, John et al. (2017) A Risk Assessment Tool for Identifying Pregnant and Postpartum Women Who May Benefit From Preexposure Prophylaxis. Clin Infect Dis 64:751-758
Roxby, Alison C; Fredricks, David N; Odem-Davis, Katherine et al. (2016) Changes in Vaginal Microbiota and Immune Mediators in HIV-1-Seronegative Kenyan Women Initiating Depot Medroxyprogesterone Acetate. J Acquir Immune Defic Syndr 71:359-66
Kinuthia, John; Drake, Alison L; Matemo, Daniel et al. (2015) HIV acquisition during pregnancy and postpartum is associated with genital infections and partnership characteristics. AIDS 29:2025-33
Masese, Linnet; Baeten, Jared M; Richardson, Barbra A et al. (2015) Changes in the contribution of genital tract infections to HIV acquisition among Kenyan high-risk women from 1993 to 2012. AIDS 29:1077-85
Unger, Jennifer A; Matemo, Daniel; Pintye, Jillian et al. (2015) Patient-Delivered Partner Treatment for Chlamydia, Gonorrhea, and Trichomonas Infection Among Pregnant and Postpartum Women in Kenya. Sex Transm Dis 42:637-42
McClelland, R Scott; Richardson, Barbra A; Cherutich, Peter et al. (2015) A 15-year study of the impact of community antiretroviral therapy coverage on HIV incidence in Kenyan female sex workers. AIDS 29:2279-86

Showing the most recent 10 out of 24 publications